Jean A. Setterstrom - Alpharetta GA, US John E. Van Hamont - Fort Meade MD, US Robert H. Reid - Kensington MD, US Elliot Jacob - Silver Spring MD, US Ramasubbu Jeyanthi - Columbia MD, US Edgar C. Boedeker - Chevy Chase MD, US Charles E. McQueen - Olney MD, US Daniel L. Jarboe - Silver Spring MD, US Frederick Cassels - Ellicott City MD, US William Brown - Denver CO, US Curt Thies - Ballwin MO, US Thomas R. Tice - Birmington AL, US F. Donald Roberts - Dover MA, US Phil Friden - Bedford MA, US
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1-100 days in an aqueous physiological environment. The microcapsules are comprised of a core of polypeptide or other biologically active agent encapsulated in a matrix of poly(lactide/glycolide) copolymer, which may contain a pharmaceutically-acceptable adjuvant, as a blend of upcapped free carboxyl end group, and end-capped forms ranging in ratios from 100/0 to 1/99.
Therapeutic Treatment And Prevention Of Infections With A Bioactive Material(S) Encapuslated Within A Biodegradable-Bio-Compatable Polymeric Matrix
Jean A. Setterstrom - Alpharetta GA, US Thomas R. Tice - Birmingham AL, US Elliot Jacob - Silver Spring MD, US Robert H. Reid - Kensington MD, US John van Hamont - West Point NY, US Edgar C. Boedecker - Crownsville MD, US Phil Friden - Bedford MA, US F. Donald Roberts - Dover MA, US Charles E. McQueen - Olney MD, US Apurba Bhattacharjee - Kensington MD, US Alan Cross - Chevy Chase MD, US Jerald Sadoff - Washington DC, US Wendell Zollinger - Silver Spring MD, US
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1-100 days in an aqueous physiological environment. The microcapsules are comprised of a core of polypeptide or other biologically active agent encapsulated in a matrix of poly(lactide/glycolide) copolymer having a molar composition of lactide/glycolide from 90/10 to 40/60, which may contain a pharmaceutically-acceptable adjuvant, as a blend of uncapped free carboxyl end group and end-capped forms ranging to ratios from 100/0 to 1/99.
Therapeutic Treatment And Prevention Of Infections With A Bioactive Materials Encapsulated Within A Biodegradable-Biocompatible Polymeric Matrix
Jean A. Setterstrom - Alpharetta GA John E. Van Hamont - Fort Meade MD Robert H. Reid - McComas CT Elliot Jacob - Silver Spring MD Ramasubbu Jeyanthi - Columbia MD Edgar C. Boedeker - Chevy Chase MD Charles E. McQueen - Olney MD Daniel L. Jarboe - Silver Spring MD Frederick Cassels - Ellicott City MD William Brown - Denver CO Curt Thies - Ballwin MO Thomas R. Tice - Birmington AL F. Donald Roberts - Dover MA Phil Friden - Beford MA
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
A61K 952 A61K 4730
US Classification:
424486
Abstract:
Novel burst-free, sustained release biocompatible and biodegrable microcapsules which can be programmed to release their active core for variable durations ranging from 1-100 days in an aqueous physiological environment. The microcapsules are comprised of a core of polypeptide or other biologically active agent encapsulated in a matrix of poly(lactide/glycolide) copolymer, which may contain a pharmaceutically-acceptable adjuvant, as a blend of upcapped free carboxyl end group and end-capped forms ranging in ratios from 100/0 to 1/99.